×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [9]
Institute of Chi... [4]
THE STATE KEY LA... [3]
Authors
ZHENG WENHUA [1]
CHEN MEIWAN [1]
LU JINJIAN [1]
CHEN XIAOJIA [1]
DAI YUNLU [1]
CHOU CHON KIT [1]
More...
Document Type
Journal article [9]
Review article [4]
Date Issued
2025 [1]
2024 [4]
2023 [1]
2022 [5]
2019 [2]
Language
英語English [12]
Source Publication
Advanced Functio... [2]
Frontiers in Imm... [2]
International Jo... [2]
Chemical Enginee... [1]
FRONTIERS IN ONC... [1]
Frontiers in Pha... [1]
More...
Indexed By
SCIE [10]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 13
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Anti-TNF therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells
Journal article
Shuyi Wang, Rufei Xiao, Yibo Chen, Yishan Ye, Tianzhen He, Yang Yang, Xin Chen, Chon-Kit Chou. Anti-TNF therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells[J]. Journal of Leukocyte Biology, 2025.
Authors:
Shuyi Wang
;
Rufei Xiao
;
Yibo Chen
;
Yishan Ye
;
Tianzhen He
; et al.
Favorite
|
IF:
3.6
/
5.2
|
Submit date:2025/01/17
Keywords: Systemic Autoinflammatory Diseases
Anti-tnf Therapy
Innate Immune Cells
Autoinflammation
Tnf Inhibitors: Tnfr1
Tnfr2
Apoptosis-Sensitizing Tumor Nanomedicine by Regulating Pyroptosis-Associated Inflammatory Cell Death
Review article
2024
Authors:
Du, Fangxue
;
Zhao, Hongxin
;
Song, Yangmeihui
;
Feng, Ziyan
;
Liu, Kai
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
4
IF:
18.5
/
19.6
|
Submit date:2024/09/03
Immune Therapy
Inflammatory Cell Death
Pyroptosis
Regulated Cell Death
Tumor Nanomedicine
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products
Journal article
Zhang, Le Le, Zhang, Du Juan, Shi, Jia Xin, Huang, Mu Yang, Yu, Jia Mei, Chen, Xu Jia, Wei, Xiao, Zou, Liang, Lu, Jin Jian. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products[J]. Phytomedicine, 2024, 132, 155828.
Authors:
Zhang, Le Le
;
Zhang, Du Juan
;
Shi, Jia Xin
;
Huang, Mu Yang
;
Yu, Jia Mei
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
3
IF:
6.7
/
6.2
|
Submit date:2024/07/04
Immunogenic Cell Death
Regulated Cell Death
Natural Products
Cancer Therapy
Tumor Immune Microenvironment
Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy
Journal article
Yang ZhanBo, Chu BiZhu, Tu Yao, Li LuLu, Chen DaWei, Huang ShouHui, Huang WenJun, Fan WeiWen, Li QinYuan, Zhang CunLong, Yuan ZiGao, Huang Jumin, Leung Elaine Lai Han, Jiang Yuyang. Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy[J]. Pharmacological Research, 2024, 206, 107271.
Authors:
Yang ZhanBo
;
Chu BiZhu
;
Tu Yao
;
Li LuLu
;
Chen DaWei
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
9.1
/
9.0
|
Submit date:2024/06/17
Dnmt
Hdac
Rig-i/mda5-mavs
Anti-pd-l1 Therapy
Tumor Immune Microenvironment
Apoptosis-Sensitizing Tumor Nanomedicine by Regulating Pyroptosis-Associated Inflammatory Cell Death
Review article
2024
Authors:
Du, Fangxue
;
Zhao, Hongxin
;
Song, Yangmeihui
;
Feng, Ziyan
;
Liu, Kai
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
4
IF:
18.5
/
19.6
|
Submit date:2024/06/05
Immune Therapy
Inflammatory Cell Death
Pyroptosis
Regulated Cell Death
Tumor Nanomedicine
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
Review article
2023
Authors:
Li, Wenting
;
Duan, Xiaobing
;
Chen, Xingxing
;
Zhan, Meixiao
;
Peng, Haichuan
; et al.
Favorite
|
TC[WOS]:
36
TC[Scopus]:
32
IF:
5.7
/
6.8
|
Submit date:2023/02/08
Adoptive Cell Therapy
Ebv-associated Cancer
Ebv-directed Vaccination
Epstein-barr Virus
Immune Checkpoint Inhibitors
Tcr-t Therapy
Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment
Journal article
Liu, Jingyang, Yu, Yang, Liu, Cun, Gao, Chundi, Zhuang, Jing, Liu, Lijuan, Wu, Qibiao, Ma, Wenzhe, Zhang, Qiming, Sun, Changgang. Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment[J]. Frontiers in Pharmacology, 2022, 13.
Authors:
Liu, Jingyang
;
Yu, Yang
;
Liu, Cun
;
Gao, Chundi
;
Zhuang, Jing
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
6
IF:
4.4
/
5.0
|
Submit date:2023/01/31
Cancer Therapy
Chemotherapeutic Agents
Combinatorial Regimens
Immunogenic Cell Death
Tumor Immune Microenvironment
Microfluidic synthesis of manganese-alginate nanogels with self-supplying H2O2 capability for synergistic chemo/chemodynamic therapy and boosting anticancer immunity
Journal article
Su, Miao, Zhu, Yueqiang, Chen, Junbin, Zhang, Beibei, Sun, Chunyang, Chen, Meiwan, Yang, Xianzhu. Microfluidic synthesis of manganese-alginate nanogels with self-supplying H2O2 capability for synergistic chemo/chemodynamic therapy and boosting anticancer immunity[J]. Chemical Engineering Journal, 2022, 435, 134926.
Authors:
Su, Miao
;
Zhu, Yueqiang
;
Chen, Junbin
;
Zhang, Beibei
;
Sun, Chunyang
; et al.
Favorite
|
TC[WOS]:
45
TC[Scopus]:
47
IF:
13.3
/
13.2
|
Submit date:2022/05/13
Anticancer Immune Response
Chemodynamic Therapy
Microfluidic Synthesis
mn2+-chelated Nanogels
Self-supplying H2o2
PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy
Journal article
Lu, Dan, Xu, Zepeng, Zhang, Ding, Jiang, Min, Liu, Kefang, He, Juanhua, Ma, Dongli, Ma, Xiaopeng, Tan, Shuguang, Gao, George F., Chai, Yan. PD-1 N58-Glycosylation-Dependent Binding of Monoclonal Antibody Cemiplimab for Immune Checkpoint Therapy[J]. Frontiers in Immunology, 2022, 13, 826045.
Authors:
Lu, Dan
;
Xu, Zepeng
;
Zhang, Ding
;
Jiang, Min
;
Liu, Kefang
; et al.
Favorite
|
TC[WOS]:
24
TC[Scopus]:
27
IF:
5.7
/
6.8
|
Submit date:2022/04/06
Antibody
Cemiplimab
Immune Checkpoint Therapy (Ict)
N58 Glycosylation
Pd-1
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Journal article
Yizhou Jiang, Limor Rubin, MD, Tangming Peng, Linlin Liu, Xingan Xing, Philip Lazarovici, Zheng WH(鄭文華). Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy[J]. International Journal of Biological Sciences, 2022, 2022(18), 459-472.
Authors:
Yizhou Jiang
;
Limor Rubin, MD
;
Tangming Peng
;
Linlin Liu
;
Xingan Xing
; et al.
Adobe PDF
|
Favorite
|
TC[WOS]:
77
TC[Scopus]:
84
IF:
8.2
/
8.3
|
Submit date:2022/08/31
Cytokine Storm
Covid-19
Sars-cov-2
Immune Response
Cytokines
Diagnosis
Therapy
Vaccination